"Disease Progression" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The worsening of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis.
| Descriptor ID |
D018450
|
| MeSH Number(s) |
C23.550.291.656
|
| Concept/Terms |
Disease Progression- Disease Progression
- Disease Progressions
- Progression, Disease
- Progressions, Disease
|
Below are MeSH descriptors whose meaning is more general than "Disease Progression".
Below are MeSH descriptors whose meaning is more specific than "Disease Progression".
This graph shows the total number of publications written about "Disease Progression" by people in this website by year, and whether "Disease Progression" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 3 | 3 |
| 1997 | 0 | 2 | 2 |
| 1998 | 0 | 1 | 1 |
| 1999 | 0 | 2 | 2 |
| 2000 | 0 | 4 | 4 |
| 2002 | 0 | 3 | 3 |
| 2003 | 0 | 6 | 6 |
| 2004 | 0 | 7 | 7 |
| 2005 | 0 | 4 | 4 |
| 2006 | 0 | 11 | 11 |
| 2007 | 0 | 9 | 9 |
| 2008 | 0 | 14 | 14 |
| 2009 | 0 | 12 | 12 |
| 2010 | 1 | 10 | 11 |
| 2011 | 0 | 8 | 8 |
| 2012 | 0 | 13 | 13 |
| 2013 | 3 | 15 | 18 |
| 2014 | 2 | 17 | 19 |
| 2015 | 2 | 26 | 28 |
| 2016 | 0 | 12 | 12 |
| 2017 | 2 | 26 | 28 |
| 2018 | 5 | 22 | 27 |
| 2019 | 3 | 27 | 30 |
| 2020 | 1 | 22 | 23 |
| 2021 | 0 | 10 | 10 |
| 2022 | 0 | 1 | 1 |
| 2023 | 0 | 7 | 7 |
| 2024 | 1 | 4 | 5 |
| 2025 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Disease Progression" by people in Profiles.
-
A zinc transporter drives glioblastoma progression via extracellular vesicles-reprogrammed microglial plasticity. Proc Natl Acad Sci U S A. 2025 May 06; 122(18):e2427073122.
-
Evolving insights into pancreatic tumor initiation and progression through DCLK1-expressing tuft cells. Dev Cell. 2025 Mar 24; 60(6):817-818.
-
Adjunctive Middle Meningeal Artery Embolization for Subdural Hematoma. N Engl J Med. 2024 Nov 21; 391(20):1890-1900.
-
Uterine carcinosarcoma: Unraveling the role of epithelial-to-mesenchymal transition in progression and therapeutic potential. FASEB J. 2024 Nov 15; 38(21):e70132.
-
MASLD does not affect fertility and senolytics fail to prevent MASLD progression in male mice. Sci Rep. 2024 07 27; 14(1):17332.
-
2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases. Arthritis Rheumatol. 2024 Aug; 76(8):1182-1200.
-
NAD deficiency contributes to progressive kidney disease in HIV-nephropathy mice. Am J Physiol Renal Physiol. 2024 Sep 01; 327(3):F450-F462.
-
Aberrant activation of AXL may drive progression of squamous cell carcinoma in CLL patients: a mechanistic study with clinical implications. Br J Cancer. 2024 Aug; 131(3):589-600.
-
Localized cardiac small molecule trajectories and persistent chemical sequelae in experimental Chagas disease. Nat Commun. 2023 10 25; 14(1):6769.
-
Vascular mechanisms leading to progression of mild cognitive impairment to dementia after COVID-19: Protocol and methodology of a prospective longitudinal observational study. PLoS One. 2023; 18(8):e0289508.